Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in RECURSION PHARMACEUTICALS IN
BNP PARIBAS FINANCIAL MARKETS holds 154,101 shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $473,090 as of 2026-Q1. The position was decreased (-85.8% shares). RXRX represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$473,090
Current Shares
154,101
Total Value Change
+$239,843
Total Shares Change
+119,597
Other major holders of RXRX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BAILLIE GIFFORD & CO
Decreased |
| 154,101 |
-85.8% |
| $473,090 |
| 0.0% |
| $3.54 |
0 |
| 2025-Q4 | Increased | 1.1M | +858.4% | $4.4M | 0.0% | $4.11 | 43 |
| 2025-Q3 | Decreased | 113,125 | -1.4% | $552,050 | 0.0% | $4.91 | 0 |
| 2025-Q2 | Increased | 114,795 | +522.7% | $580,863 | 0.0% | $5.03 | 39 |
| 2025-Q1 | Decreased | 18,435 | -46.6% | $97,521 | 0.0% | $5.81 | 0 |
| 2024-Q4 | New | 34,504 | - | $233,247 | 0.0% | $6.77 | 32 |